ARID1A and neoplasm: EMP treatment showed negligible suppressive effects on HCT116 ARID1A+/+ tumor xenografts (Fig. 2L, N), whereas it significantly inhibited HCT116 ARID1A−/− xenograft tumor growth (Fig. 2M, O).